iGMDRD17
Canonical SMILES: CC1=C(N=CN1)CSCCNC(=NC)NC#N
InChI: InChI=1S/C10H16N6S/c1-8-9(16-7-15-8)5-17-4-3-13-10(12-2)14-6-11/h7H,3-5H2,1-2H3,(H,15,16)(H2,12,13,14)
InChI Key: AQIXAKUUQRKLND-UHFFFAOYSA-N
Drug Class:
Acid ReducersAdjuvantsAlimentary Tract and MetabolismAmidinesAndrogen AntagonistsAnti-Ulcer AgentsAntiandrogensAzolesChemically-Induced DisordersCytochrome P-450 CYP1A2 InhibitorsCytochrome P-450 CYP1A2 Inhibitors (weak)Cytochrome P-450 CYP2D6 InhibitorsCytochrome P-450 CYP2D6 Inhibitors (moderate)Cytochrome P-450 CYP2D6 Inhibitors (weak)Cytochrome P-450 CYP3A InhibitorsCytochrome P-450 CYP3A4 InhibitorsCytochrome P-450 CYP3A4 Inhibitors (weak)Cytochrome P-450 CYP3A5 InhibitorsCytochrome P-450 CYP3A5 Inhibitors (moderate)Cytochrome P-450 CYP3A7 InhibitorsCytochrome P-450 CYP3A7 Inhibitors (moderate)Cytochrome P-450 Enzyme InhibitorsDrug-Related Side Effects and Adverse ReactionsDrugs for Acid Related DisordersDrugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)Enzyme InhibitorsGastrointestinal AgentsGuanidinesHeterocyclic CompoundsHeterocyclic Compounds, 1-RingHistamine AgentsHistamine AntagonistsHistamine H2 AntagonistsImidazolesMetabolic Side Effects of Drugs and SubstancesNeurotransmitter AgentsOAT1 SubstratesOAT3 SubstratesOCT2 SubstratesP-glycoprotein/ABCB1 SubstratesDrug Targets:
HRH2 (P25021)Drug Pathways:
Calcium signaling pathwayNeuroactive ligand-receptor interactionGastric acid secretionDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Loading, please wait...
Gene ID | Gene Name | Model Num. |
---|---|---|
3429 | IFI27 | 1 |
Showing 1 to 1 of 1 rows
Gene in drug-gene network: Network Plot

Models in Cimetidine
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |